Loss Executives Association

Bristol Myers Reaches $239M Settlement Over Psoriasis, MS Drugs

November 6, 2025

Bristol Myers Squibb reached a $239 million settlement of claims that former Celgene shareholders were defrauded about prospects for the psoriasis drug Otezla, and multiple sclerosis treatment now known as Zeposia. A preliminary settlement of the 7-1/2-year-old class action was …

Read the full article →

Share:

More Posts

3M to Argue Australia’s $1.4 Billion ‘Forever Chemicals’ Lawsuit Legally Flawed

U.S. conglomerate 3M plans to argue a landmark case brought by Australia over contamination from the company’s use of PFAS “forever chemicals” in its firefighting

Europe EV Sales Rose 70% in September

Battery-electric vehicle (BEV) registrations in Europe rose 70.3% in September, as high oil prices, subsidies and the availability of more affordable models continued to lead

Waymo Plans to Quintuple Fleet To 20,000, According to Reports

Alphabet’s self-driving unit Waymo plans to expand its fleet five-fold to 20,000 by the end of next year using $5 billion it raised earlier this

Send Us A Message